NeuroPace (NPCE) Stock Chart & Stock Price History $10.64 -1.03 (-8.83%) Closing price 04:00 PM EasternExtended Trading$11.12 +0.48 (+4.50%) As of 06:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NeuroPace Stock Price Performance 5 Day Performance-13.00%1 Month Performance+5.98%3 Month Performance-10.89%6 Month Performance+71.34%Year-To-Date Performance-4.92%1 Year Performance-26.72% Receive NPCE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NeuroPace and its competitors with MarketBeat's FREE daily newsletter. Email Address NPCE Stock Chart for Thursday, April, 10, 2025 NPCE Chart by TradingViewRemove Ads NeuroPace Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/10/2025$11.67$10.64-8.83%$11.56$10.43121,148 shs$346.44 million04/09/2025$11.10$11.67+5.14%$12.01$10.18276,763 shs$379.98 million04/09/2025$11.10$11.67+5.14%$12.01$10.18276,763 shs$379.98 million04/08/2025$12.30$11.10-9.76%$12.55$10.84214,425 shs$361.42 million04/08/2025$12.30$11.10-9.76%$12.55$10.84214,425 shs$361.42 million04/07/2025$12.23$12.30+0.57%$12.67$11.03219,781 shs$400.49 million04/04/2025$13.01$12.23-6.00%$12.68$11.83221,302 shs$398.21 million04/03/2025$13.54$13.01-3.91%$13.04$12.00270,601 shs$423.61 million04/02/2025$13.11$13.54+3.28%$13.60$12.54182,737 shs$440.86 million04/01/2025$12.29$13.11+6.67%$13.18$11.85209,861 shs$426.86 million Get the Latest News and Ratings for NPCE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NeuroPace and its competitors with MarketBeat's FREE daily newsletter. 03/31/2025$11.85$12.29+3.71%$12.45$11.26218,479 shs$400.16 million03/28/2025$12.38$11.85-4.28%$12.47$11.78168,073 shs$385.84 million03/27/2025$12.72$12.38-2.67%$12.74$12.08256,009 shs$403.09 million03/26/2025$12.13$12.72+4.86%$12.77$11.56292,716 shs$414.16 million03/25/2025$12.30$12.13-1.38%$12.50$11.86144,793 shs$394.95 million03/24/2025$12.02$12.30+2.33%$12.56$12.06252,393 shs$400.49 million03/21/2025$11.64$12.02+3.26%$12.09$11.25252,645 shs$391.37 million03/20/2025$11.75$11.64-0.94%$11.84$11.34252,717 shs$379.00 million03/19/2025$11.40$11.75+3.07%$12.06$11.41206,727 shs$382.58 million03/18/2025$11.24$11.40+1.42%$11.64$11.00162,159 shs$371.18 million03/17/2025$10.69$11.24+5.14%$11.47$10.56206,622 shs$365.97 million03/14/2025$10.43$10.69+2.49%$10.82$10.4997,761 shs$348.07 million03/13/2025$10.97$10.43-4.92%$11.01$10.19151,111 shs$339.60 million03/12/2025$10.36$10.97+5.89%$11.09$10.24194,441 shs$357.18 million03/11/2025$10.04$10.36+3.19%$10.42$9.56218,611 shs$337.32 million03/10/2025$11.00$10.04-8.73%$10.96$9.91216,875 shs$299.67 million Related Companies Tandem Diabetes Care Stock Price Chart Liquidia Stock Price Chart Kestra Medical Technologies Stock Price Chart InMode Stock Price Chart Cadre Stock Price Chart Establishment Labs Stock Price Chart MiMedx Group Stock Price Chart Paragon 28 Stock Price Chart BioLife Solutions Stock Price Chart Artivion Stock Price Chart Receive NPCE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NeuroPace and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NPCE) was last updated on 4/10/2025 by MarketBeat.com Staff From Our PartnersTrump’s policies mean HUGE income for investorsThanks to a Trump win… Investors have a HUGE opportunity at new income. The floodgates for U.S. oil prod...The Oxford Club | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroPace, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroPace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
